Key Drivers
- Cash Generation
- Thin Margins
- Negative Equity
AIAI Summary
Cardinal Health is increasingly a cash-generating healthcare platform rather than just a low-margin distributor, but the stock's upside depends on specialty pharma and other growth businesses sustaining momentum because thin margins, a strained balance sheet, and some earnings-quality concerns leave little room for execution slips.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Generation
- •Thin Margins
- •Negative Equity
Cardinal Health produces massive revenue and strong free cash flow, but ultra-thin margins, negative equity, tight liquidity, and a relatively expensive earnings multiple make it a cash-flow story with meaningful balance-sheet risk.
Price Behavior
Key Price Behavior Insights:
- •Downtrend intact
- •Support holding
- •Rebound testing resistance
CAH remains in a short-term downtrend, but the rebound from $182.50-$183.65 support to $195.20 shows improving momentum into $197-$198 resistance.
Sharp early-May selloff bottomed near $182.50-$183.65, then several higher closes signaled a rebound attempt
Sentiment & News
Key News Insights:
- •Specialty Growth
- •EPS Outperformance
- •Share Price Weakness
Cardinal Health's specialty drug segment is driving strong fiscal Q3 results and a higher EPS outlook, but tariff pressure, tough comps, and recent share weakness temper the otherwise improving outlook.
The news is modestly positive for CAH overall, but upside may remain capped until the market sees sustained margin expansion and less tariff-related pressure
Similar Companies in Healthcare
Other companies in the same sector with AI ratings